|4Jan 4, 5:13 PM ET

Andrews Kurt J. 4

4 · AMICUS THERAPEUTICS INC · Filed Jan 4, 2018

Insider Transaction Report

Form 4
Period: 2018-01-02
Andrews Kurt J.
SVP, Human Resources
Transactions
  • Exercise/Conversion

    Stock Options (right to buy)

    2018-01-0210,00065,000 total
    Exercise: $6.13From: 2017-02-01Exp: 2026-02-01Common Stock (10,000 underlying)
  • Exercise/Conversion

    Common Stock

    2018-01-02$14.72/sh+10,000$147,19144,737 total
  • Sale

    Common Stock

    2018-01-02$14.72/sh10,000$147,19134,737 total
Footnotes (3)
  • [F1]The exercise of stock options and subsequent sale of common stock were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 20, 2017.
  • [F2]This price is the weighted average purchase price for the transactions reported on this line. The prices for the transactions reported on this line range from $14.12 to $15.16. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
  • [F3]This price is the weighted average sale price for the transactions reported on this line. The prices for the transactions reported on this line range from $14.12 to $15.16. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION